www.blincytohcp.com – MashupMD

Mashup Score: 0

CD19-Positive B-Cell Precursor ALL Therapy | BLINCYTO® (blinatumomab) - 12 month(s) ago

Learn about BLINCYTO® (blinatumomab), a treatment for CD19-positive MRD(+), R/R, and consolidation Ph(-) B-cell precursor ALL. See Full Safety Info, including Boxed Warning.

Source: www.blincytohcp.com

Categories: General Medicine News, Payer

Tweet Tweets with this article
- AmgenOncology
  
  We’re proud to announce BLINCYTO® (blinatumomab) has received approval of a new indication from the @US_FDA. Please see Important Safety Information: https://t.co/tGCV4VUjjl Full Prescribing Information, including BOXED WARNING: https://t.co/FxarMNt2gN For U.S. audiences only. https://t.co/geTyifJ5T1

Mashup Score: 15

CD19-Positive B-Cell Precursor ALL Therapy | BLINCYTO® (blinatumomab) - 12 month(s) ago

Learn about BLINCYTO® (blinatumomab), a treatment for CD19-positive MRD(+), R/R, and consolidation Ph(-) B-cell precursor ALL. See Full Safety Info, including Boxed Warning.

Source: www.blincytohcp.com

Categories: General Medicine News, Payer

Tweet Tweets with this article
- AmgenOncology
  
  We’re proud to announce BLINCYTO® (blinatumomab) has received approval of a new indication from the @US_FDA. Please see Important Safety Information: https://t.co/mxQ4qY8keo Full Prescribing Information, including BOXED WARNING: https://t.co/tsUS91i1ac For U.S. audiences only. https://t.co/j2NAt737jK